Future of Cancer Care

Cancer stem cells (CSCs) are cancer cells (found among tumors or hematological cancers) that possess characteristics related to traditional stem cells, specifically the flexibility to offer a rise to a variety of cells found during a specific cancer sample. CSCs are so tumorigenic (tumor-forming), perhaps in contrast to alternative non-tumorigenic cancer cells. CSCs might generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell varieties. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

  • Fluid biopsy
  • Cancer Immunotherapy
  • Real-time cancer diagnostics
  • Radiation Therapy
  • Next-generation targeted therapies
  • Molecular cancer diagnostics
  • Artificial intelligence based therapy design
  • In silico trials
  • DNA cages

Related Conference of Future of Cancer Care

April 16-17, 2026

19th World Congress on Stem Cell Research

Tokyo, Japan
June 08-09, 2026

9th Global Conference on Cell and Gene Therapy

Rome, Italy
June 15-16, 2026

22nd Global Summit on Stem Cell & Regenerative Medicine

Amsterdam, Netherlands
June 15-16, 2026

13th World Congress on Epigenetics and Chromosome

Paris, France
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 25-26, 2025

6th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Future of Cancer Care Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in